Eli Lilly
-
Investing & Wealth
Lilly’s Legal Stance: Unapproved Retatrutide Sales Spark Litigation
Eli Lilly and Company has initiated legal action against six entities, alleging the illegal promotion and sale of **Retatrutide**, an…
Read More » -
Investing & Wealth
Eli Lilly’s Bold Move: Early Access to Next-Gen Obesity Drug?
Eli Lilly‘s decision to grant early access to its next-gen obesity drug marks a significant moment in the battle against…
Read More »
